Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC), 55887 [2018-24461]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 217 / Thursday, November 8, 2018 / Notices
October 5, 2018 Volume 83, Number
194, page 50378.
The call-in number and passcode
should read as follows: call-in number,
866–803–2146, passcode: 80256461.
FOR FURTHER INFORMATION CONTACT: Erin
Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE, Mailstop
A–07, Atlanta, Georgia 30329–4027;
Email: HICPAC@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–24463 Filed 11–7–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Clinical Laboratory
Improvement Advisory Committee
(CLIAC)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
CLIAC. The CLIAC, consists of 20
experts including the Chair in the fields
associated with microbiology (including
bacteriology, mycobacteriology,
mycology, parasitology, and virology),
immunology (including
histocompatibility), chemistry,
hematology, pathology (including
histopathology and cytology), genetic
testing (including cytogenetics); from
representatives in the fields of medical
technology, public health, and clinical
practice; and from consumer
representatives.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
microbiology (including bacteriology,
mycobacteriology, mycology,
parasitology, and virology), immunology
(including histocompatibility),
chemistry, hematology, pathology
(including histopathology and cytology),
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:51 Nov 07, 2018
Jkt 247001
or genetic testing (including
cytogenetics); from representatives in
the fields of medical technology, public
health, and clinical practice; and from
consumer representatives. Members
may be invited to serve for up to fouryear terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of CLIAC
objectives (https://www.cdc.gov/cliac/).
DATES: Nominations for membership on
the CLIAC must be received no later
than May 1, 2019. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Nancy Anderson, MMSc,
MT(ASCP), CLIAC Secretary, Senior
Advisor for Clinical Laboratories,
Division of Laboratory Systems, Center
for Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop V24–3,
Atlanta, Georgia 30329–4018; telephone
(404) 498–2741; or via email at
NAnderson@cdc.gov or faxed to (404)
471–2706.
FOR FURTHER INFORMATION CONTACT:
Heather Stang, MS, Deputy Branch
Chief, Quality and Safety Systems
Branch, Division of Laboratory Systems,
Center for Surveillance, Epidemiology
and Laboratory Services, Office of
Public Health Scientific Services,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE,
Mailstop V24–3, Atlanta, Georgia
30329–4018; telephone (404) 498–2769;
HStang@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. Committee members are
Special Government Employees (SGEs),
requiring the filing of financial
disclosure reports at the beginning and
annually during their terms. CDC
reviews potential candidates for CLIAC
membership each year, and provides a
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
55887
slate of nominees for consideration to
the Secretary of HHS for final selection.
HHS notifies selected candidates of
their appointment near the start of the
term in July, or as soon as the HHS
selection process is completed. Note
that the need for different expertise
varies from year to year and a candidate
who is not selected in one year may be
reconsidered in a subsequent year. SGE
Nominees must be U.S. citizens.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–24461 Filed 11–7–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2018–0103, NIOSH–
322]
Draft—National Occupational Research
Agenda for Immune, Infectious and
Dermal Disease Prevention (IID)
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for comment.
AGENCY:
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention announces the availability of
SUMMARY:
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)]
[Notices]
[Page 55887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24461]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Clinical
Laboratory Improvement Advisory Committee (CLIAC)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the CLIAC. The CLIAC, consists of
20 experts including the Chair in the fields associated with
microbiology (including bacteriology, mycobacteriology, mycology,
parasitology, and virology), immunology (including histocompatibility),
chemistry, hematology, pathology (including histopathology and
cytology), genetic testing (including cytogenetics); from
representatives in the fields of medical technology, public health, and
clinical practice; and from consumer representatives.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. Nominees will be selected based on expertise in
the fields of microbiology (including bacteriology, mycobacteriology,
mycology, parasitology, and virology), immunology (including
histocompatibility), chemistry, hematology, pathology (including
histopathology and cytology), or genetic testing (including
cytogenetics); from representatives in the fields of medical
technology, public health, and clinical practice; and from consumer
representatives. Members may be invited to serve for up to four-year
terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of CLIAC objectives (https://www.cdc.gov/cliac/).
DATES: Nominations for membership on the CLIAC must be received no
later than May 1, 2019. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Nancy Anderson, MMSc,
MT(ASCP), CLIAC Secretary, Senior Advisor for Clinical Laboratories,
Division of Laboratory Systems, Center for Surveillance, Epidemiology
and Laboratory Services, Office of Public Health Scientific Services,
Centers for Disease Control and Prevention, 1600 Clifton Road NE,
Mailstop V24-3, Atlanta, Georgia 30329-4018; telephone (404) 498-2741;
or via email at [email protected] or faxed to (404) 471-2706.
FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, Deputy Branch
Chief, Quality and Safety Systems Branch, Division of Laboratory
Systems, Center for Surveillance, Epidemiology and Laboratory Services,
Office of Public Health Scientific Services, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta,
Georgia 30329-4018; telephone (404) 498-2769; [email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens. Current participation on federal
workgroups or prior experience serving on a federal advisory committee
does not disqualify a candidate; however, HHS policy is to avoid
excessive individual service on advisory committees and multiple
committee memberships. Committee members are Special Government
Employees (SGEs), requiring the filing of financial disclosure reports
at the beginning and annually during their terms. CDC reviews potential
candidates for CLIAC membership each year, and provides a slate of
nominees for consideration to the Secretary of HHS for final selection.
HHS notifies selected candidates of their appointment near the start of
the term in July, or as soon as the HHS selection process is completed.
Note that the need for different expertise varies from year to year and
a candidate who is not selected in one year may be reconsidered in a
subsequent year. SGE Nominees must be U.S. citizens. Candidates should
submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities for both CDC and the Agency for Toxic Substances
and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-24461 Filed 11-7-18; 8:45 am]
BILLING CODE 4163-18-P
